Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-12 Sale |
2025-03-14 4:25 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
15,470 | $328.54 | $5,082,480 | 391,289 (Indirect Direct) |
View |
| 2025-03-10 Sale |
2025-03-12 4:32 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO |
258 | $323.04 | $83,344 | 10,440 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 5:40 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
14,113 | $341.32 | $4,817,104 | 14,383 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:36 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel |
415 | $335 | $139,025 | 7,290 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:31 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO |
1,961 | $324.96 | $637,248 | 6,914 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:24 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer |
1,834 | $325.98 | $597,840 | 8,604 (Direct) |
View |
| 2025-02-28 Sale |
2025-03-04 9:24 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
1,227 | $341.07 | $418,488 | 3,728 (Direct) |
View |
| 2025-02-27 Sale |
2025-02-28 4:31 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
15,470 | $347.45 | $5,375,126 | 1,912 (Direct) |
View |
| 2025-02-27 Sale |
2025-02-28 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
20,000 | $356.44 | $7,128,759 | 7,382 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 5:18 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer |
347 | $335.24 | $116,328 | 10,438 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 5:12 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO |
1,584 | $335.24 | $531,020 | 54,303 (Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 5:07 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
648 | $335.24 | $217,236 | 1,112,202 (Indirect Direct) |
View |
| 2025-01-24 Sale |
2025-01-27 5:03 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
103 | $335.24 | $34,530 | 4,955 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-17 7:10 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel |
277 | $273.41 | $75,735 | 7,705 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-17 7:08 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
442 | $273.41 | $120,847 | 5,058 (Direct) |
View |
| 2025-01-17 Sale |
2025-01-17 7:05 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
1,689 | $273.41 | $461,789 | 1,112,850 (Indirect Direct) |
View |
| 2024-12-03 Sale |
2024-12-05 4:46 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
3,600 | $315.31 | $1,135,122 | 383,547 (Indirect Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 4:16 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
3,400 | $350.3 | $1,191,028 | 387,147 (Indirect Direct) |
View |
| 2024-11-21 Sale |
2024-11-22 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer |
688 | $316.92 | $218,041 | 10,785 (Direct) |
View |
| 2024-11-07 Sale |
2024-11-08 5:07 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $350 | $1,750,000 | 16,012 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 7:01 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $300.94 | $1,504,703 | 21,012 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-11 9:51 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO |
6,363 | $243.83 | $1,551,490 | 55,887 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-10 Exercise |
2025-04-11 4:59 pm |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
9,470 | $0 | 20,482 (Direct) |
View |
| 2025-04-10 Exercise |
2025-04-11 4:59 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
9,470 | $65.06 | 20,482 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-14 4:25 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
6,000 | $111.06 | 391,289 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-14 4:25 pm |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
15,470 | $0 | 391,289 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-14 4:25 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
9,470 | $65.06 | 391,289 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:29 pm |
N/A 2035-03-10 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FOUSE JACQUALYN A Director |
2,473 | $0 | 2,473 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 5:47 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO |
35,075 | $0 | 139,378 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 5:43 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO |
10,158 | $0 | 17,072 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:40 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
6,825 | $87.92 | 14,383 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:40 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
14,113 | $0 | 14,383 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 5:40 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
3,218 | $0 | 14,383 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 5:40 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
7,288 | $87.09 | 14,383 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 5:00 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
11,763 | $0 | 1,123,965 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:50 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel |
8,555 | $0 | 15,845 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:31 pm |
N/A 2035-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer |
9,089 | $0 | 17,693 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:36 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO |
50,000 | $0 | 104,303 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:31 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
6,000 | $111.06 | 1,912 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:31 pm |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
15,470 | $0 | 1,912 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:31 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
9,470 | $65.06 | 1,912 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
4,530 | $9.45 | 7,382 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
6,000 | $111.06 | 7,382 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:30 pm |
N/A 2025-06-17 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
20,000 | $0 | 7,382 (Direct) |
View |
| 2025-02-27 Exercise |
2025-02-28 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
9,470 | $65.06 | 7,382 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 5:07 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $7.36 | 16,012 (Direct) |
View |
| 2024-11-07 Exercise |
2024-11-08 5:07 pm |
N/A 2026-08-11 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $0 | 16,012 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 7:01 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $7.36 | 21,012 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 7:01 pm |
N/A 2026-08-11 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
5,000 | $0 | 21,012 (Direct) |
View |
| 2024-09-13 Gift |
2024-09-17 8:36 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
15,000 | $0 | 390,547 (Direct) |
View |
| 2024-08-15 Option Award |
2024-08-19 8:16 pm |
N/A 2034-08-15 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel |
13,035 | $0 | 15,802 (Direct) |
View |
Ownership |
2024-08-15 7:52 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel |
0 | $0 | 6,936 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 9:46 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
1,819 | $0 | 406,652 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 9:45 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
1,819 | $0 | 3,017 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 9:42 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
1,819 | $0 | 3,017 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 9:42 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
1,819 | $0 | 12,117 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 9:41 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
1,819 | $0 | 843,094 (Direct) |
View |
| 2024-06-25 Option Award |
2024-06-27 5:03 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
5,848 | $0 | 1,799,251 (Indirect) |
View |